shortagewatch

Home / Nervous system / Ambenonium

ATC N07AA30 · Anticholinesterases · updated 2 Nov 2026

Ambenonium shortage

As of 2 Nov 2026, Ambenonium has a reported shortage in 1 of the 16 countries we track (France), covering 1 product from 0 companies.

Is there an Ambenonium shortage?

Yes. As of 2 Nov 2026, Ambenonium is reported short in 1 of the 16 countries we track: France. No company has given a return date.

Countries1/16
Products1packs or presentations
Companies00 listed
Short since17 Sep 202646 days ago
Earliest returnnot givencompany estimate
Main reasonNot stated

Timeline

France
Mytélase 10 mg, compriméMytélase 10 mg, comprimétoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Compared with similar medicines

ATC group N07AA · Anticholinesterases
Distigmine2/16Pyridostigmine2/16Ambenonium1/16Neostigmine1/16

Affected products

CountryProductCompanySinceExpected backReason
FRMytélase 10 mg, comprimé limited17 Sep 2026not givenNot stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there an Ambenonium shortage?

Yes. As of 2 Nov 2026, Ambenonium is reported short in 1 of the 16 countries we track: France. No company has given a return date.

When will Ambenonium be back in stock?

No return date has been given; France: no date given. These are company estimates reported to each authority.

Why is Ambenonium in short supply?

The most common reason reported is: not stated. Reasons by product are listed in the table below.

Which companies have Ambenonium shortages?

The registers do not name the companies.